Khamar; Bakulesh Mafatlal
Patent Applications and Registrations
Patent applications and USPTO patent grants for Khamar; Bakulesh Mafatlal.The latest application filed is for "synthesis of novel intermediate(s) for preparing rivastigmine".
Company Profile
2.27.39
- Khamar; Bakulesh Mafatlal - Ahmedabad IN
- Khamar; Bakulesh Mafatlal - Gujarat IN
- Khamar; Bakulesh Mafatlal - Almedabad IN
Patent Activity
| Patent | Date |
|---|---|
| Therapeutic cancer vaccine Grant 11,219,674 - Khamar , et al. January 11, 2 | 2022-01-11 |
| Synthesis of novel intermediate(s) for preparing rivastigmine Grant 10,882,819 - Yadav , et al. January 5, 2 | 2021-01-05 |
| Synthesis Of Novel Intermediate(s) For Preparing Rivastigmine App 20200095195 - Yadav; Jhillu Singh ; et al. | 2020-03-26 |
| Therapeutic Cancer Vaccine App 20190262443 - Khamar; Bakulesh Mafatlal ; et al. | 2019-08-29 |
| Therapeutic cancer vaccine Grant 10,335,472 - Khamar , et al. | 2019-07-02 |
| Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity App 20180042850 - Khamar; Bakulesh Mafatlal ; et al. | 2018-02-15 |
| Pharmaceutical composition of killed cells with substantially retained immunogenicity Grant 9,795,659 - Khamar , et al. October 24, 2 | 2017-10-24 |
| Stable pharmaceutical composition for atherosclerosis Grant 9,789,187 - Khamar , et al. October 17, 2 | 2017-10-17 |
| Cancer antigen Grant 9,714,275 - Modi , et al. July 25, 2 | 2017-07-25 |
| Therapeutic Cancer Vaccine App 20170157231 - Khamar; Bakulesh Mafatlal ; et al. | 2017-06-08 |
| Pharmaceutical compositions of curcumin Grant 9,474,727 - Khamar , et al. October 25, 2 | 2016-10-25 |
| Method of treating desmocollin-3 expressing cancer with Mycobacterium w Grant 9,415,078 - Khamar , et al. August 16, 2 | 2016-08-16 |
| Pharmaceutical composition of taxoids Grant 9,345,683 - Khamar , et al. May 24, 2 | 2016-05-24 |
| Pharmaceutical Composition For Treating Cancer App 20150290255 - Khamar; Bakulesh Mafatlal ; et al. | 2015-10-15 |
| Hypoglycemic compounds Grant 9,029,567 - Khamar , et al. May 12, 2 | 2015-05-12 |
| Cancer Antigen App 20140294896 - Modi; Indravadan Ambalal ; et al. | 2014-10-02 |
| Novel Dipeptidyl Peptidase Iv (dp-iv) Compounds App 20140045771 - Khamar; Bakulesh Mafatlal ; et al. | 2014-02-13 |
| Farnesoid-X-receptor antagonist as a vaccine adjuvant Grant 8,647,643 - Khamar , et al. February 11, 2 | 2014-02-11 |
| Therapeutic Cancer Vaccine App 20130330375 - Khamar; Bakulesh Mafatlal ; et al. | 2013-12-12 |
| Pharmaceutical Composition Of Taxoids App 20130310447 - Khamar; Bakulesh Mafatlal ; et al. | 2013-11-21 |
| Pharmaceutical Composition For Treating Cancer App 20130295648 - Khamar; Bakulesh Mafatlal ; et al. | 2013-11-07 |
| Dipeptidyl peptidase IV (DP-IV) compounds Grant 8,563,517 - Khamar , et al. October 22, 2 | 2013-10-22 |
| Pharmaceutical Compositions Of Curcumin App 20130225689 - Khamar; Bakulesh Mafatlal ; et al. | 2013-08-29 |
| Novel Hypoglycemic Compounds App 20130150578 - Khamar; Bakulesh Mafatlal ; et al. | 2013-06-13 |
| Novel Compounds As Dpp-iv Inhibitors And Process For Preparation Thereof App 20130137852 - Khamar; Bakulesh Mafatlal ; et al. | 2013-05-30 |
| P38 Inhibitors App 20120328574 - Modi; Indravadan Ambalal ; et al. | 2012-12-27 |
| Poly TLR antagonist Grant 8,333,978 - Modi , et al. December 18, 2 | 2012-12-18 |
| Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity App 20120308605 - Khamar; Bakulesh Mafatlal ; et al. | 2012-12-06 |
| Vaccine adjuvants Grant 8,277,778 - Khamar , et al. October 2, 2 | 2012-10-02 |
| Process for manufacturing pharmaceutical composition comprises of Mycobacterium w in the treatment of asthma (obstructive lung disease) Grant 8,153,102 - Modi , et al. April 10, 2 | 2012-04-10 |
| Method of treating human-immunodeficiency virus (HIV) disease infection Grant 8,110,204 - Khamar , et al. February 7, 2 | 2012-02-07 |
| Stable Pharmaceutical Composition For Atherosclerosis App 20120027849 - Khamar; Bakulesh Mafatlal ; et al. | 2012-02-02 |
| Vaccine Adjuvants App 20120014985 - KHAMAR; BAKULESH MAFATLAL ; et al. | 2012-01-19 |
| Vaccine adjuvants Grant 8,048,434 - Khamar , et al. November 1, 2 | 2011-11-01 |
| Vaccine Adjuvants App 20110182939 - Khamar; Bakulesh Mafatlal ; et al. | 2011-07-28 |
| Novel Dipeptidyl Peptidase Iv (dp-iv) Compounds App 20110183919 - Khamar; Bakulesh Mafatlal ; et al. | 2011-07-28 |
| Method of treating cancer Grant 7,972,609 - Khamar July 5, 2 | 2011-07-05 |
| Stable Solutions Of Sparingly Soluble Actives App 20110020440 - Modi; Indravadan Ambalal ; et al. | 2011-01-27 |
| Mitogen Activated Protein Kinase Modulator App 20100209394 - Modi; Rajiv Indravadan ; et al. | 2010-08-19 |
| Process For Preparing Amorphous Atorvastatin Hemi Calcium Salt And Its Itermediate App 20100113802 - Modi; Indravadan Ambalal ; et al. | 2010-05-06 |
| P38 Inhibitors App 20100104536 - Modi; Indravadan Ambalal ; et al. | 2010-04-29 |
| Poly Tlr Antagonist App 20100062026 - Modi; Ambalal ; et al. | 2010-03-11 |
| Novel Process For Synthesis Of Itopride And Its Novel Intermediate N-(4-hydroxybenzyl)- 3,4-dimethoxybenzamide App 20090177008 - Khamar; Bakulesh Mafatlal ; et al. | 2009-07-09 |
| Stable pharmaceutical composition of rabeprazole App 20090137633 - Khamar; Bakulesh Mafatlal ; et al. | 2009-05-28 |
| Vaccine Adjuvants App 20080131458 - Khamar; Bakulesh Mafatlal ; et al. | 2008-06-05 |
| Preparation For Methscopolamine Tannate App 20080091022 - Modi; Indravadan Ambalal ; et al. | 2008-04-17 |
| Method of treating cancer App 20070259005 - Khamar; Bakulesh Mafatlal | 2007-11-08 |
| Process for the Preparation of Losartan Potassium Form I App 20070249839 - Khamar; Bakulesh Mafatlal ; et al. | 2007-10-25 |
| Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthma (obstructive lung disease) App 20070059328 - Khamar; Bakulesh Mafatlal | 2007-03-15 |
| Stable oral pharmaceutical formulation containing an anti-infective agent and a microorganism App 20020025309 - Modi, Rajiv Indravadan ; et al. | 2002-02-28 |
| Preparation of an oral pharmaceutical formulation containing an anti-infective agent and a microorganism Grant 6,306,391 - Modi , et al. October 23, 2 | 2001-10-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 